| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000022641 |
| Receipt No. | R000025958 |
| Official scientific title of the study | The effects of monocular occlusion and Prism Adaptation Test in strabismus |
| Date of disclosure of the study information | 2016/06/10 |
| Last modified on | 2016/06/07 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | The effects of monocular occlusion and Prism Adaptation Test in strabismus | |
| Title of the study (Brief title) | The effects of monocular occlusion and Prism Adaptation Test in strabismus | |
| Region |
|
|
| Condition | ||
| Condition | strabismus | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate effective methods in order to determine the maximum angle of strabismus |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | angle of deviation |
| Key secondary outcomes | refractive error, binocular visual function |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1, monocular occlusion
2, monocular occlusion and Prism Adaptation test 3, Prism Adaptation test |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | exotropia or intermittent exotropia
esotropia or intermittent esotropia No eye disease without strabismus and refractive error normal retinal correspondence surgery purpose |
|||
| Key exclusion criteria | the lack of cooperation with examination | |||
| Target sample size | 14 | |||
| Research contact person | |
| Name of lead principal investigator | Noriko Nishikawa |
| Organization | Asahikawa Medical University |
| Division name | Department of Ophthalmology |
| Address | 1-1-1 Midorigaoka higashi 2-jo, Asahikawa, Hokkaido |
| TEL | 0166-68-2543 |
| nnori@asahikawa-med.ac.jp | |
| Public contact | |
| Name of contact person | Manami Kawai |
| Organization | Asahikawa Medical University |
| Division name | Department of Ophthalmology |
| Address | 1-1-1 Midorigaoka higashi 2-jo, Asahikawa, Hokkaido |
| TEL | 0166-68-2543 |
| Homepage URL | |
| ort-mk@asahikawa-med.ac.jp | |
| Sponsor | |
| Institute | Department of Ophthalmology, Asahikawa Medical University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025958 |